BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ahmad F, Treanor L, Mcgrath TA, Walker D, Mcinnes MD, Schieda N. Safety of Off‐Label Use of Ferumoxtyol as a Contrast Agent for MRI : A Systematic Review and Meta‐Analysis of Adverse Events. J Magn Reson Imaging 2021;53:840-58. [DOI: 10.1002/jmri.27405] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Elahi N, Rizwan M. Progress and prospects of magnetic iron oxide nanoparticles in biomedical applications: A review. Artif Organs 2021. [PMID: 34245037 DOI: 10.1111/aor.14027] [Reference Citation Analysis]
2 Queler SC, Tan ET, Geannette C, Prince M, Sneag DB. Ferumoxytol-enhanced vascular suppression in magnetic resonance neurography. Skeletal Radiol 2021. [PMID: 33961070 DOI: 10.1007/s00256-021-03804-w] [Reference Citation Analysis]
3 Ramirez-Suarez KI, Tierradentro-García LO, Otero HJ, Rapp JB, White AM, Partington SL, Harris MA, Vatsky SA, Whitehead KK, Fogel MA, Biko DM. Optimizing neonatal cardiac imaging (magnetic resonance/computed tomography). Pediatr Radiol 2021. [PMID: 34657169 DOI: 10.1007/s00247-021-05201-w] [Reference Citation Analysis]
4 Autio JA, Zhu Q, Li X, Glasser MF, Schwiedrzik CM, Fair DA, Zimmermann J, Yacoub E, Menon RS, Van Essen DC, Hayashi T, Russ B, Vanduffel W. Minimal specifications for non-human primate MRI: Challenges in standardizing and harmonizing data collection. Neuroimage 2021;236:118082. [PMID: 33882349 DOI: 10.1016/j.neuroimage.2021.118082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Shahrouki P, Felker ER, Raman SS, Jeong WK, Lu DS, Finn JP. Steady-state ferumoxytol-enhanced MRI: early observations in benign abdominal organ masses and clinical implications. Abdom Radiol (NY) 2021. [PMID: 34689252 DOI: 10.1007/s00261-021-03271-w] [Reference Citation Analysis]
6 Lim CS, Abreu-Gomez J, Thornhill R, James N, Al Kindi A, Lim AS, Schieda N. Utility of machine learning of apparent diffusion coefficient (ADC) and T2-weighted (T2W) radiomic features in PI-RADS version 2.1 category 3 lesions to predict prostate cancer diagnosis. Abdom Radiol (NY) 2021;46:5647-58. [PMID: 34467426 DOI: 10.1007/s00261-021-03235-0] [Reference Citation Analysis]
7 Shahrouki P, Nguyen KL, Moriarty JM, Plotnik AN, Yoshida T, Finn JP. Minimizing table time in patients with claustrophobia using focused ferumoxytol-enhanced MR angiography (f-FEMRA): a feasibility study. Br J Radiol 2021;94:20210430. [PMID: 34415199 DOI: 10.1259/bjr.20210430] [Reference Citation Analysis]